Product Information

DOLOBID 250 MG TABLET is a brand (anda) product labeled by INA Pharmaceutics Inc, priced at $22.8653 per EA under NDC 74157000960. Its NADAC has been published 5 times since Sep 17, 2025.

The High Outlier badge above means this manufacturer's average price in the Diflunisal market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DOLOBID 250 MG TABLET

Diflunisal
$22.8653per EA
High Outlier

Strength

250 mg/1

NDC

74157000960

Classification

Brand (ANDA)

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

DIFLUNISAL

Approval Type

Generic (ANDA)

FDA Application

ANDA202845

On Market Since

8/19/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for DOLOBID 250 MG TABLET has been published 5 times since Sep 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$22.8653 per EA
All-time high$22.8653 (Oct 15, 2025)
All-time low$22.8653 (Sep 17, 2025)
52-week high$22.8653
52-week low$22.8653
Median price$22.8653
Average price$22.8653
Largest weekly change0.0% (Sep 24, 2025)
Weeks tracked5
Tracking sinceSep 17, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Diflunisal market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DOLOBID 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DOLOBID 250 MG TABLET, manufactured by INA Pharmaceutics Inc, is $22.8653 per EA (NDC 74157000960), effective Oct 15, 2025.

How has the price of DOLOBID 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for DOLOBID 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Sep 17, 2025.

What are the highest and lowest recorded NADAC prices for DOLOBID 250 MG TABLET?

Since Sep 17, 2025, the NADAC for DOLOBID 250 MG TABLET has ranged from a low of $22.8653 (Sep 17, 2025) to a high of $22.8653 (Oct 15, 2025), with a median of $22.8653 per EA.

Are there cheaper alternatives to DOLOBID 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DOLOBID 250 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures DOLOBID 250 MG TABLET?

DOLOBID 250 MG TABLET (NDC 74157000960) is labeled by INA Pharmaceutics Inc, and CMS classifies it as a brand (anda) product.